Volume 6.48 | Dec 7

ESC & iPSC News 6.48, December 7, 2011
ESC & iPSC News
     In this issue: Publications | Industry News | Policy News | Events | Jobs
Cell Therapy News on Facebook  ESC & iPSC News on Twitter
Not All Cellular Reprogramming Is Created Equal
Tweaking the levels of factors used during the reprogramming of adult cells into induced pluripotent stem (iPS) cells greatly affects the quality of the resulting iPS cells, according to researchers. [Press release from the Whitehead Institute for Biomedical Research discussing online prepublication in Cell Stem Cell] Press Release | Abstract

Webinar: Affordable, Defined hPSC Culture? Watch the video now.
PUBLICATIONS (Ranked by Impact Factor of the Journal)

Forward and Reverse Genetics through Derivation of Haploid Mouse Embryonic Stem Cells
Here scientists report the generation of haploid mouse embryonic stem cell lines from parthenogenetic embryos. [Cell Stem Cell] Abstract

Ascorbic Acid Enhances the Cardiac Differentiation of Induced Pluripotent Stem Cells Promoting the Proliferation of Cardiac Progenitor Cells
To identify efficient inducers for cardiac differentiation and maturation of induced pluripotent stem cells (iPSCs) and elucidate the mechanisms, researchers systematically screened sixteen cardiomyocyte inducers on various murine iPSCs and found that only ascorbic acid consistently and robustly enhanced the cardiac differentiation of eleven lines including eight without spontaneous cardiogenic potential. [Cell Res] Abstract

Extensive Determination of Glycan Heterogeneity Reveals an Unusual Abundance of High-Mannose Glycans in Enriched Plasma Membranes of Human Embryonic Stem Cells
This study introduces a technique for the rapid profiling and quantitation of N- and O-glycans on cell membranes using membrane enrichment and nanoflow liquid chromatography/mass spectrometry of native structures. [Mol Cell Proteomics] Abstract

Mifepristone Inducible Caspase-1 Expression in Mouse Embryonic Stem Cells Eliminates Tumor Formation but Spares Differentiated Cells In Vitro and In Vivo
To reduce the risk and improve embryonic stem (ES) cell-based therapy, investigators have established a novel strategy by which they can selectively eliminate tumor cells derived from undifferentiated ES cells but spare differentiated cells. [Stem CellsAbstract

Efficient and Accurate Homologous Recombination in hESCs and hiPSCs Using Helper-Dependent Adenoviral Vectors
Results suggest that high-capacity helper-dependent adenoviral vector is one of the best methods for efficient and accurate gene targeting in human embryonic stem cells and human induced pluripotent stem cells and might be especially useful for therapeutic applications. [Mol Ther] Abstract

Efficient Reprogramming of Human Cord Blood CD34+ Cells into Induced Pluripotent Stem Cells with OCT4 and SOX2 Alone
Here, investigators show that the lentiviral expression of OCT4 together with SOX2 driven by a strong spleen focus-forming virus promoter in a single vector can convert 2% of cord blood CD34+ cells into induced pluripotent stem cells without additional reprogramming factors. [Mol Ther] Abstract

The Zinc Finger Protein ZFP57 Requires its Cofactor to Recruit DNA Methyltransferases and Maintains the DNA Methylation Imprint in Embryonic Stem Cells via its Transcriptional Repression Domain
To gain insights into the essential processes in genomic imprinting, scientists examined how ZFP57 maintains genomic DNA methylation imprint in mouse embryonic stem cells. [J Biol ChemAbstract

Epigenetic Modulation of miR-122 Facilitates Human Embryonic Stem Cell Self-Renewal and Hepatocellular Carcinoma Proliferation
Through a series of gene expression analysis, researchers show that miR-122 expression is highly elevated in quiescent human primary hepatocytes but lost or attenuated in human embryonic stem cells and liver cancer cells, while an opposing expression pattern is observed for Pkm2. [PLoS One] Abstract

Rational Bioprocess Design for Human Pluripotent Stem Cell Expansion and Endoderm Differentiation Based on Cellular Dynamics
Scientists present a predictive bioprocess design strategy employing cell- and molecular-level analysis of rate-limiting steps in human pluripotent stem cell expansion and differentiation, and apply it to produce definitive endoderm progenitors using a scalable directed-differentiation technology. [Biotechnol Bioeng] Abstract | Press Release

mTeSR™1 Standardizes Your hESC & hiPSC Culture - Watch the Video

Researchers Use Stem Cells to Gain New Insight into Severe Childhood Form of Epilepsy
A team of researchers investigating the fundamental cause of Dravet syndrome have reprogrammed fibroblasts from Dravet patients and generated patient-specific neurons. [Press release from the University of Michigan Health System discussing research presented at the 65th Annual Meeting of the American Epilepsy Society, Baltimore] Press Release
Stem Cells That Are Pure Enough for the Clinic
Human embryonic stem cells that are potentially pure enough to be used in therapies have been deposited into the UK Stem Cell Bank, and will soon be available across Europe. [NatureNews] Press Release

VistaGen Therapeutics and Synterys Sign Strategic Medicinal Chemistry Collaboration Agreement for Drug Rescue
VistaGen Therapeutics, Inc. and Synterys, Inc. have entered into a strategic medicinal chemistry services agreement. [Vistagen Therapeutics, Inc.] Press Release
Senate Moves Toward SBIR Reauthorization for Eight Years
The U.S. Senate expects to approve an eight-year reauthorization of the Small Business Innovation Research (SBIR) program. But it is not known if the House of Representatives will follow suit and pass it or continue to press for its own version. [US Senate, United States] Press Release

U.K. to Open Patient Data and Boost Life Science Funding
As part of a suite of measures to support the country’s life science sector, the United Kingdom plans to increase researchers’ access to medical patient data and funnel £180 million ($280 million) to a new fund designed to help turn basic science into marketable treatments, Prime Minister David Cameron announced. [British Prime Minister, United Kingdom] Press Release

UK Pumps £200 Million Back into Scientific Infrastructure
Britain’s Chancellor George Osborne announced £200 million (US$314 million) for science infrastructure projects in his annual Autumn Statement. [Britain Chancellor, United Kingdom] Press Release

European Commission Confirms New Chief Science Adviser
Two years after announcing that he will be appointing the European Union’s first chief science adviser, European Commission President José Manuel Barroso has confirmed that Scottish microbiologist Anne Glover will be taking up the job in January. [European Commission, European Union] Press Release

EU Seeks $100 Billion for Research
Despite a chaotic European economy, the European Commission has proposed a budget of €80 billion (US$106 billion) for the years 2014 to 2020, up from €50.5 billion for 2007 to 2013. [European Commission, European Union] Press Release

Science Academies at Odds Over New Law in Montenegro
A new law in Montenegro aimed at strengthening science and innovation for development has sparked a war of words between the country’s two science academies, including a call for the country’s science minister to be replaced. [The Montenegrin Academy of Sciences and Arts, Montenegro] Press Release

Adoption and Implementation of the Guide for the Care and Use of Laboratory Animals: Eighth Edition (NOT-OD-12-020) [National Institutes of Health, United States]
NEW Keystone Symposia: Cardiovascular Development and Regeneration
January 22-27, 2012
Taos, United States

our events page to see a complete list of events in the ESC & iPSC community.

Lab Technologist – Tissue Culture (STEMCELL Technologies)

Research and Development Technologist, hPSC Media (STEMCELL Technologies)

Lab Technologist – Pluripotent Stem Cells (STEMCELL Technologies)

Scientist – Pluripotent Stem Cells (STEMCELL Technologies)

Research Technologist, Manufacturing Sciences (STEMCELL Technologies)

Business Analyst – Product Management (STEMSOFT Software)

Postdoctoral Positions (National Centre for Biological Sciences)

Scientist – Differentiation Segment (Stemgent, Inc.)

Recruit Top Talent
Reach more than 11,000 potential candidates by posting your organization’s career opportunities on the Connexon Creative Job Board at no cost.

Jobs are categorized regionally: United States, Canada, Europe, Asia Pacific

Visit here to post your career opportunities.

Have we missed an important article or publication in ESC & iPSC News? Click here to submit!

Comments or Suggestions? Email [email protected] with your feedback.

Learn more about ESC & iPSC News: Archives | Events | Contact Us